Cargando…

The contribution of itch and skin severity improvements to the Dermatology Life Quality Index in patients with atopic dermatitis in baricitinib phase III trials

With data from three monotherapy baricitinib phase III randomized clinical trials (RCTs), we conducted a posthoc mediator analysis to assess whether changes in itch or skin severity mediated the treatment effect over placebo on changes in health‐related quality of life. In this analysis, baricitinib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yosipovitch, Gil, Papp, Kim, Forman, Seth, Han, George, Waibel, Jill, Rueda, Maria J., Sun, Luna, Chen, Yun‐Fei, Goldblum, Orin, Pierce, Evangeline, Silverberg, Jonathan I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322426/ https://www.ncbi.nlm.nih.gov/pubmed/35041213 http://dx.doi.org/10.1111/bjd.21015

Ejemplares similares

Current Clinical Options for the Management of Itch in Atopic Dermatitis
por: Lipman, Zoe M, et al.
Publicado: (2021)

Itch and Sleep Improvements with Baricitinib in Patients with Atopic Dermatitis: A Post Hoc Analysis of 3 Phase 3 Studies
por: Buhl, Timo, et al.
Publicado: (2021)

Neuroimmune interactions in chronic itch of atopic dermatitis
por: Yosipovitch, G., et al.
Publicado: (2019)

The direct and indirect costs of adult atopic dermatitis
por: Manjelievskaia, Janna, et al.
Publicado: (2021)

The Role of the Microbiome and Microbiome-Derived Metabolites in Atopic Dermatitis and Non-Histaminergic Itch
por: Li, Wei, et al.
Publicado: (2020)

Brain Processing of Contagious Itch in Patients with Atopic Dermatitis
por: Schut, Christina, et al.
Publicado: (2017)

Psychometric properties of the itch numeric rating scale, skin pain numeric rating scale, and atopic dermatitis sleep scale in adult patients with moderate-to-severe atopic dermatitis
por: Silverberg, Jonathan I., et al.
Publicado: (2021)

Clinical Tailoring of Baricitinib 2 mg in Atopic Dermatitis: Baseline Body Surface Area and Rapid Onset of Action Identifies Response at Week 16
por: Silverberg, Jonathan I., et al.
Publicado: (2021)

Baseline Body Surface Area and Itch Severity Define Response to Baricitinib in Patients with Moderate-to-Severe Atopic Dermatitis at Week 16
por: Thyssen, Jacob P., et al.
Publicado: (2023)

Dermatology for the internist: optimal diagnosis and management of atopic dermatitis
por: Narla, Shanthi, et al.
Publicado: (2021)

How to measure itch in atopic dermatitis?
por: Oosterhaven, J.A.F.
Publicado: (2020)

Itch in Atopic Dermatitis – What Is New?
por: Legat, Franz J.
Publicado: (2021)

Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate‐to‐severe atopic dermatitis from the BREEZE‐AD7 Phase 3 randomized trial
por: Wollenberg, A., et al.
Publicado: (2021)

Development, Psychometric Validation and Responder Definition of Worst Itch Scale in Children with Severe Atopic Dermatitis
por: Paller, Amy S., et al.
Publicado: (2022)

Baricitinib: A Review in Moderate to Severe Atopic Dermatitis
por: Hoy, Sheridan M.
Publicado: (2022)

A Qualitative Analysis of Provider Notes of Atopic Dermatitis-Related Visits Using Natural Language Processing Methods
por: Pierce, Evangeline J., et al.
Publicado: (2021)

Early Itch Response with Abrocitinib Is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE COMPARE Trial
por: Ständer, Sonja, et al.
Publicado: (2022)

Intractable Itch in Atopic Dermatitis: Causes and Treatments
por: Umehara, Yoshie, et al.
Publicado: (2021)

Treatment of Atopic Dermatitis with Baricitinib: First Real-life Experience
por: ROGNER, Danielle, et al.
Publicado: (2022)

Correction to: Baricitinib: A Review in Moderate to Severe Atopic Dermatitis
por: Hoy, Sheridan M.
Publicado: (2022)

Rapid Improvement of Itch Associated With Atopic Dermatitis With Abrocitinib Is Partially Independent of Overall Disease Improvement: Results From Pooled Phase 2b and 3 Monotherapy Studies
por: Kim, Brian S., et al.
Publicado: (2021)

Managing Atopic Dermatitis with Lebrikizumab – The Evidence to Date
por: Labib, Angelina, et al.
Publicado: (2022)

Itching in Atopic Dermatitis: Patient- and Physician-reported Outcomes in the German Atopic Dermatitis Registry TREATgermany
por: WEISSHAAR, Elke, et al.
Publicado: (2023)

Risk of Venous Thromboembolism Among Patients with Atopic Dermatitis: A Cohort Study in a US Administrative Claims Database
por: Meyers, Kristin J., et al.
Publicado: (2021)

Racial and Ethnic Differences in Sociodemographic, Clinical, and Treatment Characteristics Among Patients with Atopic Dermatitis in the United States and Canada: Real-World Data from the CorEvitas Atopic Dermatitis Registry
por: Silverberg, Jonathan I., et al.
Publicado: (2023)

Application of Baricitinib in Dermatology
por: Zhang, Jingya, et al.
Publicado: (2022)

Psychologic interventions in patients with the chronic dermatologic itch in atopic dermatitis and psoriasis: A step forward with family constellations seminars
por: Capec, Szergej, et al.
Publicado: (2022)

Breaking the Itch–Scratch Cycle: Topical Options for the Management of Chronic Cutaneous Itch in Atopic Dermatitis
por: Harrison, Ian P., et al.
Publicado: (2019)

Neural Oscillation Associated with Contagious Itch in Patients with Atopic Dermatitis
por: Lee, In-Seon, et al.
Publicado: (2021)

The Pathology of Type 2 Inflammation-Associated Itch in Atopic Dermatitis
por: Moniaga, Catharina Sagita, et al.
Publicado: (2021)

Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial
por: Reich, Kristian, et al.
Publicado: (2020)

Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: Focus on Abrocitinib, Baricitinib, and Upadacitinib
por: Nogueira, Miguel, et al.
Publicado: (2021)

Baricitinib Lipid-Based Nanosystems as a Topical Alternative for Atopic Dermatitis Treatment
por: Garrós, Núria, et al.
Publicado: (2023)

Exploring content and psychometric validity of newly developed assessment tools for itch and skin pain in atopic dermatitis
por: Newton, Louise, et al.
Publicado: (2019)

Neutrophils promote CXCR3-dependent itch in the development of atopic dermatitis
por: Walsh, Carolyn M, et al.
Publicado: (2019)

Is Itch Intensity in Atopic Dermatitis Associated with Skin Colonization by Staphylococcus aureus?
por: Blicharz, Leszek, et al.
Publicado: (2020)

An Altered Skin and Gut Microbiota Are Involved in the Modulation of Itch in Atopic Dermatitis
por: Moniaga, Catharina Sagita, et al.
Publicado: (2022)

A New Generation of Treatments for Itch
por: FOWLER, Emilie, et al.
Publicado: (2020)

Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate‐to‐severe atopic dermatitis
por: Yosipovitch, G., et al.
Publicado: (2019)

Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis
por: de Bruin-Weller, Marjolein S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hn512nva95surbnh1us7mbalaa